NanoRepro AG
NN6 | F
Overview
Corporate Details
- ISIN(s):
- DE0006577109
- LEI:
- 3912008FCA63AGIMEV74
- Country:
- Germany
- Address:
- UNTERGASSE 8, 35037 MARBURG
- Website:
- https://www.nanorepro.com/en/
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
NanoRepro AG, based in Marburg an der Lahn, specializes in the development, manufacture and national and international distribution of medical self-tests and is primarily active in health planning and prevention. The company addresses a rapidly growing market, which is characterized by the steadily increasing health awareness of the population and will continue to gain in importance in the coming years. NanoRepro has 24 rapid tests in its portfolio and is continuously expanding it. Among others, the company has already established 2 pregnancy tests, a test for male fertility determination, a test for gastric health as well as a range of different allergy tests and tests for preventive health care on the market.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-26 14:01 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-05-19 12:01 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-05-08 15:01 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | |
| 2025-04-29 14:00 |
Regulatory News Service
NanoRepro AG: NanoRepro AG investiert in Kaltplasma-Technologie und baut ihre M…
|
German | 11.4 KB | |
| 2025-04-16 14:00 |
Regulatory News Service
NanoRepro AG: NanoRepro erhalt EU-Qualitatsmanagementbescheinigung nach Verordn…
|
German | 8.9 KB | |
| 2025-03-27 15:46 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | |
| 2025-03-26 16:01 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | |
| 2025-02-26 09:45 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-02-25 09:45 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-02-18 12:20 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-02-17 12:20 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-02-17 12:20 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | |
| 2025-01-09 10:30 |
Earnings Release
NanoRepro AG: Erfolgreiche Unternehmensentwicklung und vielversprechende Fortsc…
|
German | 14.4 KB | |
| 2025-01-08 10:30 |
Earnings Release
NanoRepro AG: Erfolgreiche Unternehmensentwicklung und vielversprechende Fortsc…
|
German | 14.4 KB | |
| 2024-10-29 12:15 |
Directors' Dealings
NanoRepro AG: Dr. Olaf Stiller, Kauf
|
German | 7.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-25 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 14,506.24 EUR |
| 2025-02-17 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 18,750.00 EUR |
| 2024-10-29 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 17,300.00 EUR |
| 2024-10-22 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,949.96 EUR |
| 2024-10-22 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,500.00 EUR |
| 2024-10-21 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,750.00 EUR |
| 2024-10-21 | Stiller, Johanna | Close relation | Buy | None | 3,759.00 EUR |
| 2024-08-30 | ASS GmbH | Close relation | Buy | None | 30,644.30 EUR |
| 2024-07-25 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 3,279.18 EUR |
| 2024-07-24 | Jüngst, Lisa | Board | Buy | None | 21,762.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret AS | Türkiye | GENIL | |
|
Gvs | Italy | GVS | |
|
Haleon PLC | United Kingdom | HLN | |
|
I.Ceram | France | ALICR | |
|
PolyPeptide Group AG | Switzerland | PPGN | |
|
Safe S.A. | France | ALSAF | |
|
Sartorius Stedim Biotech | France | DIM | |
|
SKAN Group AG | Switzerland | SKAN | |
|
Slavej AD | North Macedonia | SLAV | |
|
Zur Rose Group AG | Switzerland | ROSE |